The "Global Cholera Vaccines Market 2018-2022" report has been added to Research and Markets' offering.

The cholera vaccines market appears to be concentrated due to the presence of few established players. The major vendors in the market compete based on pricing and presence across the world. The presence of a rich pipeline, strategic partnerships, and operational base are the other major competitive factors among cholera vaccine manufacturers. Cholera vaccines can be segmented into three product types which includes Shanchol, DUKORAL, and Vaxchora. Shanchol segment accounted for the major share of the cholera vaccines market. Cholera is very common in countries such as Congo, Yemen, South Sudan, Mozambique, and Haiti and these countries are the major adopters of Shanchol since this vaccine provides better long-term protection for children especially under the age of six. The global cholera vaccines market is forecast to grow at a CAGR of 9.56% during the period 2018-2022.

The report, Global Cholera Vaccines Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key questions answered in this report

  • What will the market size be in 2022 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?

Key Topics Covered:

  • Executive Summary
  • Scope Of The Report
  • Research Methodology
  • Market Landscape
  • Market Sizing
  • Five Forces Analysis
  • Pipeline Landscape
  • Market Segmentation By Product
  • Segmentation By Geography
  • Decision Framework
  • Drivers And Challenges
  • Market Trends
  • Vendor Landscape
  • Vendor Analysis

Companies Mentioned

  • PaxVax
  • Sanofi
  • Valneva

For more information about this report visit https://www.researchandmarkets.com/research/gxkksh/global_cholera?w=4